Wellington, New Zealand Clinical Trials

Adenocarcinoma

Merck Sharp & Dohme (New Zealand) Ltd. Updated

A clinical trial to evaluate treatments using Pembrolizumab, Cisplatin, 5-FU and Capecitabine for patients with Gastric Adenocarcinoma. Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Arthritis and Arthritic Pain

Capital and Coast District Health Board Radiology Services (X-Rays only) Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Clinical Trial Unit Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Site Reference ID/Investigator# 139031

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 139355

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 139356

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

View More »

Site Reference ID/Investigator# 141721

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Wellington Hospital Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Wellington Hospital, Clinical Trial Unit, Level 8 Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Atherosclerosis

Research Site Updated

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Atrial Fibrillation

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Brain Tumor

Site Reference ID/Investigator# 143890

Patients are needed to participate in a clinical research study evaluating ABT-414, Radiation, Temozolomide and Placebo for ABT-414 for the treatment of Glioblastoma or Gliosarcoma

Breast Cancer

Merck Sharp & Dohme (New Zealand) Ltd.

A clinical trial to evaluate treatments using Pembrolizumab for patients with Breast Cancer, Triple-Negative Breast Cancer

COPD (Chronic Obstructive Pulmonary Disease)

Medical Research Institute of New Zealand

A clinical trial to evaluate treatments using NHF with Oxygen using myAIRVO™ 2 and NHF without Oxygen using myAIRVO™ 2 for patients with Chronic Obstructive Pulmonary Disease or COPD, COPD Exacerbation

Crohn's Disease

Site Reference ID/Investigator# 139031

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 139355

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 139356

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 141721

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Diabetes Mellitus, Type 2

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Merck Sharp & Dohme (New Zealand) Ltd.

A clinical trial to evaluate treatments for patients with Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd.

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 2

Merck Sharp & Dohme (New Zealand) Ltd.

A clinical trial to evaluate treatments using MK-8521, Placebo, Liraglutide and Metformin for patients with Type II Diabetes Mellitus (MK-8521-004)

View More »

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating Ertugliflozin and Placebo for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd. Updated

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study for the treatment of Type 2 Diabetes Mellitus (T2DM)

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Diabetic Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Gastric Cancer

Merck Sharp & Dohme (New Zealand) Ltd. Updated

A clinical trial to evaluate treatments using Pembrolizumab, Cisplatin, 5-FU and Capecitabine for patients with Gastric Adenocarcinoma. Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-062/KEYNOTE-062)

Glaucoma

Capital Eye Specialists

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Heart Failure

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating Vericiguat and Placebo for Vericiguat for the treatment of Heart Failure or Chronic Heart Failure With Reduced Ejection Fraction

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Hemodialysis

Wellington Hospital

A Phase 3 clinical study for patients with Acute Kidney Injury (STARRT-AKI: Principal Trial)

High Blood Pressure (Hypertension)

Capital Eye Specialists

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Hypertriglyceridemia

Research Site Updated

Patients are needed to participate in a clinical research study of Epanova® (omega-3 carboxylic acids) and corn oil control to evaluate Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)

Kidney Disease

Research Site

A clinical trial seeking patients for a research study for the treatment of Diabetic Kidney Disease

Research Site

A clinical trial to evaluate treatments using Finerenone (BAY94-8862) and Placebo for patients with Diabetic Kidney Disease

Lung Disease

Medical Research Institute of New Zealand

A clinical trial to evaluate treatments using NHF with Oxygen using myAIRVO™ 2 and NHF without Oxygen using myAIRVO™ 2 for patients with Chronic Obstructive Pulmonary Disease or COPD, COPD Exacerbation

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Lung Injury

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Lymphoma

Merck Sharp & Dohme (New Zealand) Ltd. Updated

A clinical trial seeking patients for a research study for the treatment of Melanoma, Lymphoma or Solid Tumor

Melanoma

Merck Sharp & Dohme (New Zealand) Ltd. Updated

A clinical trial seeking patients for a research study for the treatment of Melanoma, Lymphoma or Solid Tumor

Merck Sharp & Dohme (New Zealand) Ltd.

A Phase 1/Phase 2 clinical study for patients with Melanoma

Multiple Myeloma

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating lenalidomide, dexamethasone and pembrolizumab for the treatment of Multiple Myeloma (MK-3475)

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial seeking patients for a research study for the treatment of Refractory or Relapsed Multiple Myeloma (rrMM) (MK-3475-183/KEYNOTE-183)

Neoplasm Metastasis

1160.189.64201 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Neoplasms

Research Site

A clinical research study of Trabectedin, DOXIL and Dexamethasone for the treatment of Ovarian Neoplasms, Peritoneal Neoplasms or Fallopian Tube Neoplasms

Ocular Hypertension

Capital Eye Specialists

Patients are needed to participate in a clinical research study evaluating Bimatoprost sustained-release, Sham, Timolol and Timolol Vehicle (placebo) for the treatment of Glaucoma, Open-Angle or Ocular Hypertension

Pneumonia

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating ceftolozane/tazobactam and Meropenem for the treatment of Nosocomial Pneumonia

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating TR-701 FA IV and Linezolid for the treatment of Pneumonia

Rheumatoid Arthritis

Capital and Coast District Health Board Radiology Services (X-Rays only) Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Clinical Trial Unit Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Site Reference ID/Investigator# 139031

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 139355

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Site Reference ID/Investigator# 139356

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

View More »

Site Reference ID/Investigator# 141721

A clinical trial to evaluate treatments for patients with Crohn's Disease, Rheumatoid Arthritis or Psoriasis

Wellington Hospital Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Wellington Hospital, Clinical Trial Unit, Level 8 Updated

A clinical research study of tofacitinib, adalimumab and etanercept for the treatment of Arthritis, Rheumatoid

Solid Tumors

Merck Sharp & Dohme (New Zealand) Ltd.

A Phase 1/Phase 2 clinical study for patients with Melanoma

Stroke

1160.189.64201 Boehringer Ingelheim Investigational Site

Patients are needed to participate in a clinical research study to evaluate Stroke or Secondary Prevention (RE-SPECT ESUS)

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Research Site

A Phase 3 clinical study for patients with Active Systemic Lupus Erythematosus

Ulcerative Colitis

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Ulcers

Bowen Hospital

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Vascular Diseases

Merck Sharp & Dohme (New Zealand) Ltd. Updated

Patients are needed to participate in a clinical research study evaluating Ertugliflozin and Placebo for the treatment of Type 2 Diabetes Mellitus